Variant report
Variant | nsv1026710 |
---|---|
Chromosome Location | chr8:52488839-52508868 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554108932 | chr8:52496835-52496836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117322585 | chr8:52496850-52496851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35552488 | chr8:52496888-52496889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546240758 | chr8:52497025-52497026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564576474 | chr8:52497039-52497040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568148717 | chr8:52497133-52497134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35450297 | chr8:52497146-52497147 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs543684484 | chr8:52497162-52497163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6473628 | chr8:52497178-52497179 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs75782599 | chr8:52497185-52497186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547388697 | chr8:52497200-52497201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565626552 | chr8:52497202-52497203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562652363 | chr8:52497210-52497211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532791805 | chr8:52497266-52497267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184970068 | chr8:52497278-52497279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569452489 | chr8:52497299-52497300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545494404 | chr8:52497312-52497313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371703818 | chr8:52497317-52497318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148768622 | chr8:52497318-52497319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73572306 | chr8:52497419-52497420 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570643978 | chr8:52497426-52497427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536113359 | chr8:52497427-52497428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78172881 | chr8:52497434-52497435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539295355 | chr8:52497451-52497452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535437331 | chr8:52497456-52497457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572361871 | chr8:52497476-52497477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374858368 | chr8:52497482-52497483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367866282 | chr8:52497483-52497484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188517359 | chr8:52497550-52497551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550623076 | chr8:52497603-52497604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115859931 | chr8:52497623-52497624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561829121 | chr8:52497644-52497645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78528389 | chr8:52497674-52497675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541271011 | chr8:52497707-52497708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559435470 | chr8:52497712-52497713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35923500 | chr8:52497716-52497717 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs10282811 | chr8:52497725-52497726 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs375069501 | chr8:52497735-52497736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569391028 | chr8:52497755-52497756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10107128 | chr8:52497762-52497763 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs548685480 | chr8:52497794-52497795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568274381 | chr8:52497828-52497829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535677173 | chr8:52497863-52497864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181610400 | chr8:52497893-52497894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79076444 | chr8:52497915-52497916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186279767 | chr8:52497926-52497927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558154056 | chr8:52497990-52497991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372554869 | chr8:52498012-52498013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576518368 | chr8:52498047-52498048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142484073 | chr8:52498082-52498083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52496800-52497200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
2 | chr8:52496800-52502800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:52498000-52498600 | Enhancers | Esophagus | oesophagus |
4 | chr8:52498400-52498800 | Enhancers | Left Ventricle | heart |
5 | chr8:52498800-52499200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:52498800-52506200 | Weak transcription | Left Ventricle | heart |
7 | chr8:52499200-52502400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr8:52500400-52501400 | Enhancers | Brain Germinal Matrix | brain |
9 | chr8:52502400-52502800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr8:52502400-52502800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr8:52502400-52502800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr8:52502400-52503400 | Enhancers | NH-A | brain |
13 | chr8:52502600-52503000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr8:52502600-52503000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr8:52502600-52503000 | Enhancers | Right Ventricle | heart |
16 | chr8:52506200-52506400 | Enhancers | Left Ventricle | heart |
17 | chr8:52506400-52506800 | Enhancers | Fetal Kidney | kidney |